Pam Murphy | Investor Relations |
Mark Murray | CEO |
Mike Sofia | Chief Scientific Officer |
Gaston Picchio | Chief Development Officer |
Dave Hastings | Chief Financial Officer |
Katherine Xu | William Blair |
Keay Nakae | Chardan |
Mayank Mamtani | B Riley |
Good day, ladies and gentlemen. And welcome to Arbutus Biopharma Fourth quarter and 2018 Year-End Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time [Operator Instructions].
As a reminder, today's conference is being recorded.